跳到正文
原文
MedPage Today·· 18 天前精选AI 评分64

脊柱融合手术在脊柱狭窄治疗中无显著优势

Another Surgical Treatment for Back Pain Fails in Rigorous Analysis

AI 导读

挪威全国健康登记数据显示,脊柱融合手术与单纯减压手术在治疗脊柱狭窄方面无显著差异,均未显著改善患者 Oswestry 痛症指数评分。研究还发现,脊柱融合手术增加了手术时间和住院天数,且并发症风险更高。

推荐理由

研究对比了脊柱融合手术与单纯减压手术的效果,未发现脊柱融合有显著优势,提示应重新评估相关指南。

正文

— Norwegian registry data show no benefit from spine fusion as part of decompression surgery

by John Gever, Contributing Writer, MedPage Today

November 2, 2026 • 3 min read

  • Many patients experiencing degenerative spondylolisthesis, a common feature in spinal stenosis, ultimately undergo surgical decompression with fusion, but evidence that fusion improves outcomes has been mixed.
  • This study was a so-called target trial emulation that sought to compare patients' outcomes in a national registry.
  • With data from more than 2,200 patients, no significant difference in pain and disability was seen after 12 months with fusion versus decompression alone.

Spinal fusion added to decompression surgery in patients with spinal stenosis did not provide any added benefit versus decompression alone, Norwegian national registry data indicated.

With outcomes compared for 1,446 patients undergoing decompression alone and 806 having spinal fusion as well, no significant difference in Oswestry Disability Index (ODI) scores was seen a year later, according to James H. McAuley, PhD, of Neuroscience Research Australia in Randwick, and colleagues.

This is not the first study to question the utility of spinal fusion for patients with degenerative stenosis, the group noted in their report appearing in Annals of Internal Medicine. Earlier, prospective trials in Sweden and Norway found no improvement in disability when compared with decompression surgery alone, as did a smaller U.S.-based study (although the latter did show better quality of life with fusion). Moreover, these trials all showed a higher burden of complications such as bleeding with spinal fusion, along with prolonged operative time and increased costs.

Nevertheless, McAuley and colleagues observed, including fusion in decompression procedures is now common practice in some countries, particularly the U.S. and Australia. One analysis in 2023 found that fully 90% of U.S. surgeries for degenerative spondylolisthesis in 2019 involved spine fusion -- a 23-point increase from just 3 years previously. McAuley's group had no explanation for this explosion in popularity, while the authors of the 2023 analysis pointed to "financial incentives, lack of guidelines and/or national regulations, and delayed evidence dissemination through medical education or professional societies."

Degenerative spondylolisthesis is a common feature of spinal stenosis; it involves a forward shift in a vertebra relative to those below it. Some surgeons have viewed this as indicative of instability that should be rectified via fusion, which seems plausible on its face but, as noted above, rigorous evidence for actual benefit is weak at best.

The current study sought to extend the findings from that Norwegian trial, called NORDSTEN-DS, by examining spinal stenosis patients' outcomes as recorded in the country's national health registry. They identified a total of some 3,900 patients undergoing surgery for degenerative spondylolisthesis from 2007 to 2021. NORDSTEN-DS participants' data were included in the registry and analyzed anew in the current study, which used a "target trial emulation" approach to compare patients undergoing versus not having fusion as part of decompression surgery. After excluding patients who, for example, were very elderly or had previous surgeries in the same spinal region, the investigators had 2,252 patients for detailed analysis, including 236 who were in NORDSTEN-DS.

Mean patient age was about 65 and roughly 70% were women. ODI scores at the time of surgery averaged 38.9 for those having decompression alone and 41.4 for the group undergoing fusion (higher scores indicate worse symptoms, and the maximum is 50).

At month 12 after surgery, mean ODI scores declined to 20.0 for the fusion group and 22.3 among those undergoing decompression alone. The mean difference of 2.2 points fell short of statistical significance (95% CI -1.6 to 6.1).

McAuley and colleagues also performed some subgroup analyses to see whether patients who would be more likely to benefit from fusion could be identified from baseline characteristics, such as age, sex, body mass index, or symptom severity. This effort came up empty, as no significant differences in ODI improvement emerged. However, it did show that men with obesity (BMI ≥30) had significantly worse outcomes versus men with lower BMI values.

And, as with earlier studies, fusion led to longer operative time (mean 85 extra minutes) and longer hospital stays (mean 1.9 extra days) compared with decompression alone. Although no particular complication stood out as more common with fusion, the risk for any type of complication was doubled overall. Risk for needing additional surgery because of complications was increased even more.

"This study calls into question the highly prevalent management of pain from lumbar degenerative spondylolisthesis with fusion," McAuley and colleagues wrote. "Our findings add to current evidence and should prompt reevaluation of current guidelines," which, they noted, are sparse and "offer conflicting recommendations."

Limitations to the study included the reliance on administrative records, the potential for confounding by unmeasured variables, and the 12-month window for examining outcomes, leaving open the possibility that fusion could have longer-term benefits.

来源:MedPage Today · medpagetoday.com